Transcatheter Aortic Valve Replacement Market Growth & Trends
The global transcatheter aortic valve replacement market size is estimated to reach USD 11.76 billion by 2033, registering a CAGR of 5.99% from 2025 to 2033, according to a new report by Grand View Research, Inc. The rising geriatric population and the prevalence of risk factors like aortic valve stenosis (AS) and other diseases continue to drive the demand for transcatheter aortic valve replacement (TAVR) procedures. According to the World Heart Federation 2022, rheumatic heart disease affected 39 million individuals globally. It is a disorder in which rheumatic fever permanently damages the heart valves. According to a January 2022 published study titled "Uncovering the treatable burden of severe AS in the U.K.", the prevalence of severe AS in the U.K. in 2019 was 1.48%, affecting 291,448 men and women aged 55 or above.
As a result of these figures, the demand for TAVR is expected to rise in the coming years, contributing to the market's expansion. Furthermore, the rising prevalence of heart valve disease and increased regulatory approvals for novel and sophisticated TAVR devices drive market growth. The rising prevalence of AS disease is a main factor driving the market's expansion. For instance, in January 2022, JenaValve Technology, Inc. formed a strategic alliance with an exclusive technology licensing agreement with Peijia Medical Limited in China. According to the terms of the deal, Peijia has been granted exclusive rights in China to produce and distribute JenaValve's Trilogy TAVR systems for treating patients with significant symptomatic aortic regurgitation (AR) and severe symptomatic AS.
Request a free sample copy or view report summary: Transcatheter Aortic Valve Replacement Market Report
Transcatheter Aortic Valve Replacement Market Report Highlights
- Based on the implantation procedure, the transfemoral segment held the largest market share of 51.50% in terms of revenue in 2024. Transfemoral is the most performed procedure in comparison with transapical, transaortic, and other implantation procedures. Moreover, smaller profile devices and expandable sheaths can be successfully delivered via the transfemoral technique.
- Based on material, the nitinol segment held the largest market share of 35.34% in 2024. Nitinol has strong biological and elastic properties, making it an ideal material for transcatheter heart valves.
- Based on the mechanism, the balloon-expandable valve segment held the largest market share of 55.68% in 2024. It promises robust growth due to its higher gradients when deployed in bicuspid anatomies and due to an increase in the rate of annular ruptures.
- Based on end-use, the hospital segment accounted for the largest market share of 88.02% in 2024. This is mainly due to the increasing patient base, increased TAVR procedures undertaken in hospitals, and favorable reimbursement scenarios.
- In 2024, North America dominated the global market with a share of around 38.68%. The primary drivers for market expansion are the rising prevalence of heart valve illness, the increased number of heart valve replacement procedures, product advancements, and the well-established healthcare infrastructure.
Access Press Release@ https://www.grandviewresearch.com/press-release/global-transcatheter-aortic-valve-replacement-tavr-devices-market
Transcatheter Aortic Valve Replacement Market Segmentation
Grand View Research has segmented the global transcatheter aortic valve replacement market based on implantation procedure, material, mechanism, end-use, and region:
Transcatheter Aortic Valve Replacement Implantation Procedure Outlook (Revenue USD Million, 2021 - 2033)
- Transfemoral
- Transapical
- Transaortic
Transcatheter Aortic Valve Replacement Material Outlook (Revenue USD Million, 2021 - 2033)
- Nitinol
- Cobalt Chromium
- Stainless Steel
- Others
Transcatheter Aortic Valve Replacement Mechanism Outlook (Revenue USD Million, 2021 - 2033)
- Balloon-expandable
- Self-expandable
Transcatheter Aortic Valve Replacement End-use Outlook (Revenue USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
Transcatheter Aortic Valve Replacement Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- US.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players in the Transcatheter Aortic Valve Replacement Market
- Medtronic
- Abbott
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd
- Edwards Lifesciences Corporation
- Anteris Technologies
- Venus Medtech (Hangzhou) Inc.
- JenaValve
- Biosensors International Group, Ltd.
- HLT Medical (Bracco)
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.